Are You Ready For Pharma Tariff Shifts? A Survey Report
Potential U.S. tariffs are forcing pharma and life sciences companies to re-evaluate suppliers, sourcing strategies, and digital capabilities. But, shifting global supply chains is slow and complex in a tightly regulated industry. Our new survey reveals how prepared companies are and what steps can strengthen resilience in this high-stakes environment.
Get insights on:
Where pharma companies are most vulnerable and what’s blocking supply chain transformation
How cost pressures are reshaping sourcing and investment decisions
How automation, AI, and digital solutions help companies gain a competitive edge
If your supply chain relies on global partners, this is a must-read report to help you plan smarter and act faster.
